Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1991;81(3):287-95.
doi: 10.1007/BF00305870.

Striatonigral degeneration, olivopontocerebellar atrophy and "atypical" Pick disease

Affiliations
Case Reports

Striatonigral degeneration, olivopontocerebellar atrophy and "atypical" Pick disease

D S Horoupian et al. Acta Neuropathol. 1991.

Abstract

A 75-year-old woman with parkinsonism plus was found at autopsy to have striatonigral degeneration (SND), olivopontocerebellar atrophy (OPCA) and intracytoplasmic neuronal inclusions, mostly confined to the hippocampus and pontine nuclei. These inclusions were intensely argyrophilic, ubiquitinated and expressed variable immunoreactivity for neurofilament but not for tau-1 and Alz 50 proteins. Ultrastructurally, they were formed of skeins of intermediate filaments averaging 11 nm in diameter. They were considered to represent Pick bodies. There was no cortical atrophy, gliosis or sponginess. To our knowledge, SND and OPCA in association with Pick's disease has not been previously reported. In addition, intracytoplasmic oligodendroglial inclusions were present in the deeper layers of the cortex, especially the pericentral gyri, the striatum and the white matter of certain regions of the cerebral hemispheres, as well as in the cerebellum. These inclusions which have been previously reported in multisystem atrophy, had to be distinguished from cortical Lewy bodies, Pick bodies, and the nonspecific ubiquitinated bodies in the white matter of the aged brain, mainly by their topographical distribution and immunostaining properties.

PubMed Disclaimer

References

    1. Clin Neuropathol. 1989 Jan-Feb;8(1):1-6 - PubMed
    1. Arch Neurol. 1968 Jan;18(1):20-33 - PubMed
    1. Rev Neurol (Paris). 1981;137(1):33-8 - PubMed
    1. Acta Neuropathol. 1989;79(1):10-7 - PubMed
    1. J Neuropathol Exp Neurol. 1982 Nov;41(6):664-75 - PubMed

Publication types

LinkOut - more resources